Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Establishment Labs Holdings Inc (ESTA)
NASDAQ:ESTA
RESEARCH TOOLSreports
Holding ESTA?
Track your performance easily
ESTA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$16.96 - $60.12
Previous Close$42.33
Volume119.54K
Average Volume (3M)287.72K
Market Cap
$1.23B
Enterprise Value$1.32B
Total Cash (Recent Filing)$54.60M
Total Debt (Recent Filing)$196.72M
Price to Earnings (P/E)―
Beta1.53
Next Earnings
Nov 05, 2024EPS Estimate
-$0.61Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.11
Shares Outstanding27,943,534
10 Day Avg. Volume170,866
30 Day Avg. Volume287,721
Standard Deviation0.17
R-Squared0.13
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)26.29
Price to Sales (P/S)8.04
Price to Cash Flow (P/CF)-21.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.75
Enterprise Value/Gross Profit12.39
Enterprise Value/Ebitda147.40
Forecast
1Y Price Target
$58.00Price Target Upside31.85% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Establishment Labs Holdings News
PremiumCompany Announcements
Establishment Labs Appoints New President Peter Caldini
Bulls Say, Bears Say
Bulls Say
Financial GuidanceESTA's initial sales guidance for the year outpaces market expectations, signaling strong revenue growth and confidence from management.
Market ExpansionThe anticipated launch of Motiva in China, coupled with the expanding presence in Asia and Europe, forecasts dynamic growth opportunities for ESTA.
Regulatory ApprovalManagement's expectation of a successful FDA review for Motiva implants hints at a new product launch, potentially boosting the company's market presence.
Bears Say
Financial CovenantsTranche D of the credit facility requires both Tranche C to be drawn and trailing twelve-month sales to exceed $195M.
Market DemandAcknowledging the recent slowdown in demand for breast procedures globally, management said distributor ordering patterns had an outsized impact on Q3 results.
Sales PerformanceAcknowledging the recent slowdown in demand for breast procedures globally, management again said distributor ordering patterns had an outsized impact on Q3 results while direct markets only experienced a single-digit decline.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
ESTA FAQ
What was Establishment Labs Holdings Inc’s price range in the past 12 months?
Establishment Labs Holdings Inc lowest stock price was $16.96 and its highest was $60.12 in the past 12 months.
What is Establishment Labs Holdings Inc’s market cap?
Currently, no data Available
When is Establishment Labs Holdings Inc’s upcoming earnings report date?
Establishment Labs Holdings Inc’s upcoming earnings report date is Nov 05, 2024 which is in 46 days.
How were Establishment Labs Holdings Inc’s earnings last quarter?
Establishment Labs Holdings Inc released its earnings results on Aug 06, 2024. The company reported -$0.62 earnings per share for the quarter, missing the consensus estimate of -$0.513 by -$0.107.
Is Establishment Labs Holdings Inc overvalued?
According to Wall Street analysts Establishment Labs Holdings Inc’s price is currently Undervalued.
Does Establishment Labs Holdings Inc pay dividends?
Establishment Labs Holdings Inc does not currently pay dividends.
What is Establishment Labs Holdings Inc’s EPS estimate?
Establishment Labs Holdings Inc’s EPS estimate is -$0.61.
How many shares outstanding does Establishment Labs Holdings Inc have?
Establishment Labs Holdings Inc has 27,943,535 shares outstanding.
What happened to Establishment Labs Holdings Inc’s price movement after its last earnings report?
Establishment Labs Holdings Inc reported an EPS of -$0.62 in its last earnings report, missing expectations of -$0.513. Following the earnings report the stock price went down -2.655%.
Which hedge fund is a major shareholder of Establishment Labs Holdings Inc?
Among the largest hedge funds holding Establishment Labs Holdings Inc’s share is Royce & Associates LLC. It holds Establishment Labs Holdings Inc’s shares valued at N/A.
---
Establishment Labs Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$58.00 (31.85% Upside)
$58.00 (31.85% Upside)
Blogger Sentiment
Bullish
ESTA Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 97.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 2.8%
Last 30 Days ▲ 2.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-18.68%
12-Months-Change
Fundamentals
Return on Equity
-166.58%
Trailing 12-Months
Asset Growth
-0.07%
Trailing 12-Months
Company Description
Establishment Labs Holdings Inc
Establishment Labs Holdings, Inc. engages in the design, development, manufacture, and marketing of silicone breast implants. It offers its products under Motiva Implants brand. The company was founded by Juan Jose Chacon-Quiros in 2013 and is headquartered in Alajuela, Costa Rica.
---
ESTA Earnings Call
Q2 2024
0:00 / 0:00
---
ESTA Stock 12 Month Forecast
Average Price Target
$58.00
▲(31.85% Upside)
Technical Analysis
Best Analysts Covering ESTA
1 Year
1 Year Success Rate
7/16 ratings generated profit
1 Year Average Return
+7.37%
reiterated a buy rating 2 months ago
Copying Josh Jennings's trades and holding each position for 1 Year would result in 43.75% of your transactions generating a profit, with an average return of +7.37% per trade.
---